Market Share of Lateral Flow Assay Industry
The lateral flow assay market is moderately competitive and consists of several major players. Some of the companies are expanding their market positions by adopting various strategies, such as mergers and acquisitions, while others are developing new test methods for diagnosis and introducing new products to retain their market shares. For instance, in February 2019, Abbott announced the availability of its latest rapid influenza diagnostic test (RIDT), BinaxNOW Influenza A & B Card 2, which was granted under the Clinical Laboratory Improvements Amendments (CLIA) by the United States Food and Drug Administration (FDA) for rapid detection of influenza virus, positively impacting the market. Some of the companies currently dominating the market are Abbott Laboratories, Hologic Inc., Quidel Corporation, PerkinElmer Inc., and bioMerieux SA.
Lateral Flow Assays Market Leaders
-
Quidel Corporation
-
Hologic Inc
-
bioMérieux SA
-
Abbott Laboratories (Alere Inc)
-
PerkinElmer Inc
*Disclaimer: Major Players sorted in no particular order
